Envestnet Asset Management Inc Bristol Myers Squibb CO Transaction History
Envestnet Asset Management Inc
- $302 Billion
- Q3 2024
A detailed history of Envestnet Asset Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Envestnet Asset Management Inc holds 2,913,065 shares of BMY stock, worth $163 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,913,065
Previous 2,268,887
28.39%
Holding current value
$163 Million
Previous $94.2 Million
59.99%
% of portfolio
0.05%
Previous 0.03%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,536Shares Held
1.46BCall Options Held
31.6MPut Options Held
35M-
Vanguard Group Inc Valley Forge, PA189MShares$10.5 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.86 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.19 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.35 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA61MShares$3.41 Billion0.61% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $119B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...